Financial results - BACMEDPHARM SRL

Financial Summary - Bacmedpharm Srl
Unique identification code: 35775603
Registration number: J04/358/2016
Nace: 4619
Sales - Ron
48.505
Net Profit - Ron
34.176
Employee
1
The most important financial indicators for the company Bacmedpharm Srl - Unique Identification Number 35775603: sales in 2023 was 48.505 euro, registering a net profit of 34.176 euro and having an average number of 1 employees. Firma isi desfasoara activitatea in domeniul Intermedieri in comertul cu produse diverse having the NACE code 4619.

Sales, Profit, Employees, Debts, Capitals, Financial Results - Bacmedpharm Srl

2014 2015 2016 2017 2018 2019 2020 2021 2022 2023
Sales - EUR - - 27.416 33.427 43.367 36.890 36.399 39.765 43.038 48.505
Total Income - EUR - - 27.416 33.427 43.367 36.890 36.400 39.765 43.038 48.505
Total Expenses - EUR - - 7.726 9.835 8.844 10.106 2.004 640 10.615 13.854
Gross Profit/Loss - EUR - - 19.690 23.593 34.523 26.784 34.396 39.125 32.423 34.652
Net Profit/Loss - EUR - - 19.101 23.259 34.090 26.415 33.384 38.016 32.001 34.176
Employees - - 1 1 1 1 1 0 1 1
Tabelul prezinta cei mai importanti indicatori ai firmei din Contul de Profit si Pierderi pentru ultimii 10 ani de activitate asa cum se regasesc la Ministerul de Finante. Datele ofera evolutia firmei in aceasta perioada privind cresterile si eventual descresterile inregistrate. In the last year of activity, the sales increased by 13.0%, from 43.038 euro in the year 2022, to 48.505 euro in 2023. The Net Profit increased by 2.272 euro, from 32.001 euro in 2022, to 34.176 in the last year.

Check the financial reports for the company - Bacmedpharm Srl

Rating financiar

Financial Rating -
Bacmedpharm Srl

See the company's note based on the submitted financial data, relative to the industry of which it is a part.

Check Financial Rating
Limite de plata

Payment Limits -
Bacmedpharm Srl

See the company's payment capacity for situations in which you conclude contracts with payment terms.

Check Payment Limits
Probabilitate de insolventa

Prob. of insolvency -
Bacmedpharm Srl

It determines the risk of insolvency based on the submitted accounting balance.

Check Insolvency Probability
Rapoarte financiare

Financial Reports -
Bacmedpharm Srl

Check all the financial reports of the company and know the risks in collaboration with it.

Check Financial Reports
Financial Analysis Reports provide a clear and comprehensive view of a company's financial activity. In addition to presenting financial data, the reports analyze this data so that any user can understand whether the results are positive or less favorable. The Financial Rating provides an analysis based on the most important financial ratios, including liquidity, solvency, and profitability. Payment Limits represent the maximum amounts for which a company can offer goods or services on credit to its clients. The Probability of Insolvency presents the theoretical probability that a company may not be able to meet its financial obligations towards its creditors, i.e., suppliers and financial institutions.

Debts, Equity, Inventories, Receivables, Accounts, Assets - Bacmedpharm Srl - CUI 35775603

2014 2015 2016 2017 2018 2019 2020 2021 2022 2023
Fixed Assets - - 72 1.316 831 386 0 0 0 0
Current Assets - - 19.847 23.356 34.409 60.457 33.730 39.002 33.281 35.667
Inventories - - 0 0 0 0 0 0 0 0
Receivables - - 0 0 0 0 0 0 0 21.643
Cash - - 19.847 23.356 34.409 60.457 33.730 39.002 33.281 14.024
Shareholders Funds - - 19.146 23.473 34.141 59.895 33.433 38.066 32.050 34.225
Social Capital - - 45 44 43 42 41 40 41 40
Debts - - 773 1.199 1.099 948 297 936 1.231 1.442
Income in Advance - - 0 0 0 0 0 0 0 0
Exchange rate - RON 4.9465 4.9315 4.9468 4.8371 4.7454 4.6535 4.5681 4.4908 4.445 4.4821
Main CAEN "4619 - 4619"
CAEN Financial Year 4619
The table presents the company's Balance Sheet structure for the last 10 years. Current Assets recorded a value of 35.667 euro in 2023 which includes Inventories of 0 euro, Receivables of 21.643 euro and cash availability of 14.024 euro.
The company's Equity was valued at 34.225 euro, while total Liabilities amounted to 1.442 euro. Equity increased by 2.272 euro, from 32.050 euro in 2022, to 34.225 in 2023.

Activate the Financial Reports subscription with unlimited access and check the evolution and current financial situation of any company.

Subscriptions Financial Reports

You can check the financial situation of the companies in relation to the industry of which it is a part, credit limits and the risk of insolvency and suspension of accounts.

Subscription cost is per user. You can pay simultaneously up to 10 users.
RisCo Subscriptions offer the greatest flexibility in choosing the best services according to the needs of each user. These are structured into categories based on the type of service desired, as well as on different service contract periods: monthly, semi-annually, and annually. Check out the subscription offer for the best choices!

Reviews - Bacmedpharm Srl

Comments - Bacmedpharm Srl

Similar services useful for checking companies and business development.

Contacts Firms

Get the contact details for any company and get in touch with it.

Sectoral Studies

Knows the market and develops its own development strategies according to sectorial data.

Company Lists

Create lists of companies for your sales activity according to your own criteria.

Import - Export

Find importers and exporters according to the type of activity and the countries in which they carry it out.

Similar services represent services associated with companies that allow for a better analysis of clients and suppliers. Company Contacts help you get in touch with the desired companies. Sector Studies provide an overview of an industry, the most important competitors, and the geographical distribution of companies. Company Lists allow you to attract new clients, while Import-Export services give you access to companies engaged in such activities.